Global X Longevity Thematic ETF LNGR 深 沪
等待开盘 12-03 09:30:00 美东时间
27.75
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 27.75
- 总市值 4023.20万
- 52周最高 28.5131
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 18.8472
- 委 比 0.00%
- 总股本 144.98万
- 历史最高 28.5131
- 量 比 0
- 振 幅 0.00%
- 历史最低 13.0547
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Longeveron® Co-Founder and Chief Science Officer Dr. Joshua Hare Interviewed on NPR’s BioTech Nation Discussing Potential Breakthrough Stem Cell Therapy for Hypoplastic Left Heart Syndrome (HLHS), a Rare Pediatric Congenital Heart Defect
Longeveron announced the full enrollment of its pivotal Phase 2b clinical trial (ELPIS II) evaluating laromestrocel as a potential treatment for hypoplastic left heart syndrome (HLHS), a rare and severe congenital heart defect. ELPIS II is expected to release top-line results in the third quarter of 2026, following encouraging outcomes from the Phase 1 trial, which showed 100% transplant-free survival in treated patients up to age five. The thera...
10-27 13:15
